• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水蛭素从包覆有疏水改性葡聚糖的脂质体或脂质组装体中的稳定化及释放。

The stabilization and release of hirudin from liposomes or lipid-assemblies coated with hydrophobically modified dextran.

作者信息

Mumper R J, Hoffman A S

机构信息

Center for Pharmaceutical Science & Technology, College of Pharmacy, University of Kentucky, Lexington, Kentucky 40536-0082, USA.

出版信息

AAPS PharmSciTech. 2000 Mar 3;1(1):E3. doi: 10.1208/pt010103.

DOI:10.1208/pt010103
PMID:14727852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2784830/
Abstract

Hirudin is a 65-amino acid peptide and the most potent and specific known inhibitor of thrombin (K(i) = 0.2 pM). The short elimination half-life of hirudin from the body (1 hour) necessitates the use of a sustained and controlled delivery system. A proliposome method was used to entrap hirudin in liposomes coated with palmitoyl dextran-coated liposomes and lipid-assemblies. In vitro release studies of hirudin were performed using the lipid systems enclosed in dialysis membranes or deposited in the pores of a vascular graft. The activity of hirudin and released hirudin was measured using a thrombin chromogenic substrate assay. Entrapment efficiencies of hirudin in lipid-assemblies approached 100%, however, the release of hirudin from these systems was rapid with 90% released in 17 hours. Entrapment efficiencies of hirudin in coated-liposomes ranged from 5% to 55% and were dependent on several variables. Palmitoyl dextran- coated-liposomes showed a burst of 30% hirudin released in 5 hours with an additional 10% to 35% released over the next 600 hours. In all samples, 30-40% of the hirudin remained associated with the lipid-systems even after 600 hours. The released hirudin retained only 33% of its ability to inhibit thrombin when released from uncoated liposomes. However, hirudin retained 95% of its thrombin inhibitory activity when released from palmitoyl dextran-coated liposomes. Coated liposomes were found to stabilize hirudin and result in greater retention of hirudin's ability to inhibit thrombin's enzymatic activity, although the mechanism is not yet understood.

摘要

水蛭素是一种由65个氨基酸组成的肽,是已知的对凝血酶最有效且最具特异性的抑制剂(抑制常数K(i)=0.2皮摩尔)。水蛭素在体内的消除半衰期较短(1小时),因此需要使用持续且可控的给药系统。采用前体脂质体方法将水蛭素包裹于涂有棕榈酰葡聚糖的脂质体和脂质组装体中。使用包裹在透析膜中的脂质系统或沉积在血管移植物孔隙中的脂质系统进行水蛭素的体外释放研究。使用凝血酶显色底物分析法测量水蛭素及其释放出来的水蛭素的活性。水蛭素在脂质组装体中的包封率接近100%,然而,水蛭素从这些系统中的释放速度很快,17小时内释放了90%。水蛭素在包衣脂质体中的包封率在5%至55%之间,且取决于几个变量。棕榈酰葡聚糖包衣脂质体显示,5小时内有30%的水蛭素突发释放,在接下来的600小时内又有10%至35%的释放。在所有样品中,即使在600小时后,仍有30%-40%的水蛭素与脂质系统相关联。当从未包衣的脂质体中释放时,释放出来的水蛭素仅保留其抑制凝血酶能力的33%。然而,当从棕榈酰葡聚糖包衣脂质体中释放时,水蛭素保留了其95%的凝血酶抑制活性。尽管其机制尚不清楚,但发现包衣脂质体可使水蛭素稳定,并使其抑制凝血酶酶活性的能力得到更大程度的保留。

相似文献

1
The stabilization and release of hirudin from liposomes or lipid-assemblies coated with hydrophobically modified dextran.水蛭素从包覆有疏水改性葡聚糖的脂质体或脂质组装体中的稳定化及释放。
AAPS PharmSciTech. 2000 Mar 3;1(1):E3. doi: 10.1208/pt010103.
2
Surface modification with PEG and hirudin for protein resistance and thrombin neutralization in blood contact.表面修饰聚乙二醇和水蛭素以抵抗蛋白质吸附和中和血液接触中的凝血酶。
Colloids Surf B Biointerfaces. 2010 Dec 1;81(2):389-96. doi: 10.1016/j.colsurfb.2010.07.024. Epub 2010 Jul 15.
3
Effects of site specific amino acid exchanges in hirudin on the thrombin-hirudin interaction.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(1-2):24-9.
4
Effects of hirudin (thrombin specific inhibitor) in zebrafish embryos: a developmental role for thrombin.
Blood Cells Mol Dis. 1997 Dec;23(3):410-4. doi: 10.1006/bcmd.1997.0158.
5
Stability of hirudin, a thrombin-specific inhibitor. The structure of alkaline-inactivated hirudin.
J Biol Chem. 1991 Jun 15;266(17):10839-43.
6
Structure-activity relationships of recombinant hirudins.重组水蛭素的构效关系
Semin Thromb Hemost. 1991 Apr;17(2):94-8. doi: 10.1055/s-2007-1002595.
7
Effect of Sulfotyrosine and Negatively Charged Amino Acid of Leech-Derived Peptides on Binding and Inhibitory Activity Against Thrombin.蚓激酶多肽的磺酸酪氨酸和带负电荷氨基酸对凝血酶的结合和抑制活性的影响。
Chembiochem. 2024 Feb 1;25(3):e202300744. doi: 10.1002/cbic.202300744. Epub 2023 Dec 20.
8
[Hirudin and hirudin fragments].
Ann Cardiol Angeiol (Paris). 1992 Oct;41(8):A49-53.
9
Determination of r DNA hirudin and A-human thrombin- hirudin complex in plasma samples: enzyme linked immunosorbent assays for hirudin and complex vs. chromogenic thrombin substrate assay.血浆样本中重组DNA水蛭素和A-人凝血酶-水蛭素复合物的测定:水蛭素及复合物的酶联免疫吸附测定法与发色凝血酶底物测定法的比较
Thromb Res. 1992 Apr 1;66(1):33-42. doi: 10.1016/0049-3848(92)90153-2.
10
Preparation of dextran-bound recombinant hirudin and its pharmacokinetic behaviour.
Biomed Biochim Acta. 1990;49(10):1103-8.

引用本文的文献

1
Cationic Polymethacrylate-Modified Liposomes Significantly Enhanced Doxorubicin Delivery and Antitumor Activity.阳离子聚丙烯酸酯修饰的脂质体显著增强阿霉素的递送和抗肿瘤活性。
Sci Rep. 2017 Feb 22;7:43036. doi: 10.1038/srep43036.
2
Preparation, cellular uptake and angiogenic suppression of shikonin-containing liposomes in vitro and in vivo.含紫草素脂质体在体内外的制备、细胞摄取及血管生成抑制作用
Biosci Rep. 2013 Feb 1;33(2):e00020. doi: 10.1042/BSR20120065.
3
Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium.用于阿昔洛韦钠控释全身给药的多囊泡脂质体长效注射系统的设计与开发
AAPS PharmSciTech. 2005 Sep 20;6(1):E35-41. doi: 10.1208/pt060108.

本文引用的文献

1
A simplified spectrophotometric determination of ester groups in lipids.脂质中酯基的简化分光光度测定法。
Biochim Biophys Acta. 1959 Jul;34:244-5. doi: 10.1016/0006-3002(59)90255-0.
2
Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography.通过凝胶渗透色谱法分析阿霉素共轭聚(乙二醇)-聚(天冬氨酸)嵌段共聚物的胶束形成
Pharm Res. 1993 Jun;10(6):895-9. doi: 10.1023/a:1018921513605.
3
Healing of arterial prostheses in man: its incompleteness.人体动脉假体的愈合:其不完整性。
Ann Surg. 1972 Jan;175(1):118-27. doi: 10.1097/00000658-197201000-00018.
4
Thrombin interactions with hirudin.
Semin Thromb Hemost. 1989 Jul;15(3):265-8. doi: 10.1055/s-2007-1002718.
5
Site specific radioiodination of recombinant hirudin.
Anal Biochem. 1990 Sep;189(2):186-91. doi: 10.1016/0003-2697(90)90105-i.
6
Bifunctional thrombin inhibitors based on the sequence of hirudin45-65.
J Biol Chem. 1990 Dec 15;265(35):21698-703.
7
Hirudin and derivatives as anticoagulant agents.水蛭素及其衍生物作为抗凝剂。
Thromb Haemost. 1991 Jul 12;66(1):141-52.
8
A fast photometric assay for the determination of hirudin.一种用于测定水蛭素的快速光度测定法。
Haemostasis. 1991;21 Suppl 1:36-40. doi: 10.1159/000216261.
9
Preparation of dextran-bound recombinant hirudin and its pharmacokinetic behaviour.
Biomed Biochim Acta. 1990;49(10):1103-8.
10
A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes.
J Pharm Pharmacol. 1991 Mar;43(3):154-61. doi: 10.1111/j.2042-7158.1991.tb06657.x.